NF-κB activity is also linked to sorafenib resistance in CD13+ hepatocellular carcinoma cell lines by controlling genes that regulate cell cycle and apoptosis (Hu et al, 2020). The gene discussed is NFKB1; the disease is hepatocellular carcinoma.